Matthew Ho
Impact in
- Hematology top 5%
- Multiple Myeloma Research and Treatments
- Organic Chemistry top 5%
- Catalytic C–H Functionalization Methods
- Sulfur-Based Synthesis Techniques
- Radical Photochemical Reactions
- Catalytic Cross-Coupling Reactions
Papers in
-
- Protein Degradation and Inhibitors 14
- Ubiquitin and proteasome pathways 7
- Extracellular vesicles in disease 3
- Hematology 20
- Multiple Myeloma Research and Treatments 20
- Co-authors
- Matthew B. Plutschack (1 shared paper)Florian Berger (1 shared paper)Nils Frank (1 shared paper)Wanwan Yu (1 shared paper)Tobias Ritter (1 shared paper)Amanda McCann (8 shared papers)Giada Bianchi (13 shared papers)Luke Gubbins (2 shared papers)
- Journals
- Blood (3 papers)Journal of Clinical Oncology (2 papers)Leukemia (2 papers)Blood Cancer Journal (2 papers)Current Reviews in Musculoskeletal Medicine (1 paper)
- Partner nations
- United StatesIrelandChina
In The Last Decade
Matthew Ho
37 papers receiving 1.6k citations
Matthew Ho's Hit Papers
Peers
Comparison fields: 5 of 104
- Hematology 211
- Organic Chemistry 563
- Cancer Research 185
- Oncology 289
- Pharmaceutical Science 70
Countries citing papers authored by Matthew Ho
This map shows the geographic impact of Matthew Ho's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew Ho with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew Ho more than expected).
Fields of papers citing papers by Matthew Ho
This network shows the impact of papers produced by Matthew Ho. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew Ho. The network helps show where Matthew Ho may publish in the future.
Co-authors
The 25 scholars most cited alongside Matthew Ho, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 42 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Site-selective and versatile aromatic C−H functionalization by thianthrenation Hit paper breakdown → | 2019 | 604 |
| 2 | The fate of chemoresistance in triple negative breast cancer (TNBC) Hit paper breakdown → | 2015 | 317 |
| 3 | 2019 | 92 | |
| 4 | 2017 | 81 | |
| 5 | 2018 | 66 | |
| 6 | 2020 | 57 | |
| 7 | 2020 | 49 | |
| 8 | 2017 | 46 | |
| 9 | 2020 | 30 | |
| 10 | 2017 | 30 | |
| 11 | 2017 | 30 | |
| 12 | 2021 | 20 | |
| 13 | 2019 | 18 | |
| 14 | 2022 | 17 | |
| 15 | 2023 | 13 | |
| 16 | 2021 | 12 | |
| 17 | 2020 | 12 | |
| 18 | 2017 | 10 | |
| 19 | 2020 | 10 | |
| 20 | 2021 | 9 |
About Matthew Ho
Matthew Ho is a scholar working on Molecular Biology, Hematology, Oncology, Surgery and Pathology and Forensic Medicine, having authored 42 papers that have together received 1.6k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (20 papers), Protein Degradation and Inhibitors (14 papers), Ubiquitin and proteasome pathways (7 papers), Peptidase Inhibition and Analysis (4 papers), Immunotherapy and Immune Responses (3 papers), Extracellular vesicles in disease (3 papers), MicroRNA in disease regulation (3 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (2 papers). The work is most often cited by research in Hematology (211 citations), Organic Chemistry (563 citations), Cancer Research (185 citations), Oncology (289 citations) and Pharmaceutical Science (70 citations). Matthew Ho has collaborated with scholars based in United States, Ireland and China. Frequent co-authors include Matthew B. Plutschack, Florian Berger, Nils Frank, Wanwan Yu, Tobias Ritter, Amanda McCann, Giada Bianchi, Luke Gubbins, Karolina Weiner‐Gorzel and Kenneth C. Anderson. Their work appears in journals such as Blood, Journal of Clinical Oncology, Leukemia, Blood Cancer Journal and Current Reviews in Musculoskeletal Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.